Drug packaging should have taboo instructions

It has become a trend that major illnesses are going to hospitals and minor illnesses into pharmacies. Many people will buy their own medicines after they become ill. However, some domestically produced drugs do not have “contraindications”, and contraindications to joint-venture drugs are often found in boxes, which affects the rational drug use of drug purchasers. Not long ago, a friend bought a box of “Children's Tylenol” produced by Johnson & Johnson in a pharmacy. There are no contraindications on the outer packaging box of the medicine. Can go home to open a look, the instructions read "Asthma banned," and just happened to your friend's daughter with asthma. In the pharmacy, there are not many taboo instructions on the packaging boxes of imported and joint-venture drugs. Such as a kind of Japanese medicine Miya BM tablet for acute and chronic intestinal infections, its "side effects" must open the adhesive seal of the kit to be seen, of course, the pharmacy does not allow you to open the package and then buy the drug. Some domestic drugs are even more abrupt, and there is no indication of contraindications in the manual, such as antiviral granules, compound stomach acumen, and sensory health. For this reason, the author appealed that manufacturers should note the taboo on the packaging of pharmaceuticals. At the same time, the drug administration departments must increase supervision to ensure that the people's drug use is safe, reasonable, and effective.